How Europe Made Better H1N1 Vaccine Choices than the USA
The Wall Street Journal describes how Europe made better choices than the USA in regards to H1N1 vaccines * Europe choose to use adjuvants An adjuvanted H1N1 vaccine being used in Europe contains 3.75 micrograms of vaccine stock. The same vaccine in the U.S., without the adjuvant, requires 15 micrograms of vaccine for equal potency. …